Current Understanding of the Human Microbiome in Glioma

Overview

Journal Front Oncol

Specialty Oncology

Date 2022 Aug 25

PMID 36003766

Authors

Jianhao Liang

Ting Li

Jiajia Zhao

Cheng Wang

Haitao Sun

Affiliations

Soon will be listed here.

Abstract

There is mounting evidence that the human microbiome is highly associated with a wide variety of central nervous system diseases. However, the link between the human microbiome and glioma is rarely noticed. The exact mechanism of microbiota to affect glioma remains unclear. Recent studies have demonstrated that the microbiome may affect the development, progress, and therapy of gliomas, including the direct impacts of the intratumoral microbiome and its metabolites, and the indirect effects of the gut microbiome and its metabolites. Glioma-related microbiome (gut microbiome and intratumoral microbiome) is associated with both tumor microenvironment and tumor immune microenvironment, which ultimately influence tumorigenesis, progression, and responses to treatment. In this review, we briefly summarize current knowledge regarding the role of the glioma-related microbiome, focusing on its gut microbiome fraction and a brief description of the intratumoral microbiome, and put forward the prospects in which microbiome can be applied in the future and some challenges still need to be solved.

Citing Articles

Bacteria invade the brain following intracortical microelectrode implantation, inducing gut-brain axis disruption and contributing to reduced microelectrode performance.

Hoeferlin G, Grabinski S, Druschel L, Duncan J, Burkhart G, Weagraff G Nat Commun. 2025; 16(1):1829.

PMID: 39979293 PMC: 11842729. DOI: 10.1038/s41467-025-56979-4.

Transforming bacterial pathogens into wonder tools in cancer immunotherapy.

Senevirathne A, Lloren K, Aganja R, Kwon J, Lee J Mol Ther. 2025; 33(3):866-882.

PMID: 39825565 PMC: 11897747. DOI: 10.1016/j.ymthe.2025.01.029.

Omnigene-Gut ensures fecal microbiome stability in the pediatric population.

Hoogendijk R, van den Broek T, Lee H, Mueller S, Kline C, Bianco J AMB Express. 2024; 14(1):132.

PMID: 39641864 PMC: 11624167. DOI: 10.1186/s13568-024-01798-x.

Modulation of the Immune Environment in Glioblastoma by the Gut Microbiota.

Green G, Cox-Holmes A, Potier A, Marlow G, McFarland B Biomedicines. 2024; 12(11).

PMID: 39594997 PMC: 11591702. DOI: 10.3390/biomedicines12112429.

Microbial Biomarkers in Liquid Biopsy for Cancer: An Overview and Future Directions.

Luo F, Wang X, Ye C, Sun H Cancer Control. 2024; 31:10732748241292019.

PMID: 39431347 PMC: 11500238. DOI: 10.1177/10732748241292019.

References

Friedrich M, Hahn M, Michel J, Sankowski R, Kilian M, Kehl N . Dysfunctional dendritic cells limit antigen-specific T cell response in glioma. Neuro Oncol. 2022; 25(2):263-276. PMC: 9925697. DOI: 10.1093/neuonc/noac138. View

Meyer C, Martin-Blondel G, Liblau R . Endothelial cells and lymphatics at the interface between the immune and central nervous systems: implications for multiple sclerosis. Curr Opin Neurol. 2017; 30(3):222-230. DOI: 10.1097/WCO.0000000000000454. View

Friedman H, Kerby T, Calvert H . Temozolomide and treatment of malignant glioma. Clin Cancer Res. 2000; 6(7):2585-97. View

Brown C, Starr R, Aguilar B, Shami A, Martinez C, DApuzzo M . Stem-like tumor-initiating cells isolated from IL13Rα2 expressing gliomas are targeted and killed by IL13-zetakine-redirected T Cells. Clin Cancer Res. 2012; 18(8):2199-209. PMC: 3578382. DOI: 10.1158/1078-0432.CCR-11-1669. View

Yang W, Yu T, Huang X, Bilotta A, Xu L, Lu Y . Intestinal microbiota-derived short-chain fatty acids regulation of immune cell IL-22 production and gut immunity. Nat Commun. 2020; 11(1):4457. PMC: 7478978. DOI: 10.1038/s41467-020-18262-6. View

van Lith S, Navis A, Verrijp K, Niclou S, Bjerkvig R, Wesseling P . Glutamate as chemotactic fuel for diffuse glioma cells: are they glutamate suckers?. Biochim Biophys Acta. 2014; 1846(1):66-74. DOI: 10.1016/j.bbcan.2014.04.004. View

Lisi L, Ciotti G, Braun D, Kalinin S, Curro D, Dello Russo C . Expression of iNOS, CD163 and ARG-1 taken as M1 and M2 markers of microglial polarization in human glioblastoma and the surrounding normal parenchyma. Neurosci Lett. 2017; 645:106-112. DOI: 10.1016/j.neulet.2017.02.076. View

Fan Y, Su Q, Chen J, Wang Y, He S . Gut Microbiome Alterations Affect Glioma Development and Foxp3 Expression in Tumor Microenvironment in Mice. Front Oncol. 2022; 12:836953. PMC: 8957261. DOI: 10.3389/fonc.2022.836953. View

Masui K, Tanaka K, Ikegami S, Villa G, Yang H, Yong W . Glucose-dependent acetylation of Rictor promotes targeted cancer therapy resistance. Proc Natl Acad Sci U S A. 2015; 112(30):9406-11. PMC: 4522814. DOI: 10.1073/pnas.1511759112. View

10.

Kabat A, Srinivasan N, Maloy K . Modulation of immune development and function by intestinal microbiota. Trends Immunol. 2014; 35(11):507-17. PMC: 6485503. DOI: 10.1016/j.it.2014.07.010. View

11.

Wegiel B, Vuerich M, Daneshmandi S, Seth P . Metabolic Switch in the Tumor Microenvironment Determines Immune Responses to Anti-cancer Therapy. Front Oncol. 2018; 8:284. PMC: 6099109. DOI: 10.3389/fonc.2018.00284. View

12.

Dzutsev A, Badger J, Perez-Chanona E, Roy S, Salcedo R, Smith C . Microbes and Cancer. Annu Rev Immunol. 2017; 35:199-228. DOI: 10.1146/annurev-immunol-051116-052133. View

13.

Bobeff E, Szczesna D, Bienkowski M, Janczar K, Chmielewska-Kassassir M, Wisniewski K . Plasma amino acids indicate glioblastoma with ATRX loss. Amino Acids. 2021; 53(1):119-132. DOI: 10.1007/s00726-020-02931-3. View

14.

Ochi A, Nguyen A, Bedrosian A, Mushlin H, Zarbakhsh S, Barilla R . MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells. J Exp Med. 2012; 209(9):1671-87. PMC: 3428946. DOI: 10.1084/jem.20111706. View

15.

Allnutt M, Johnson K, Bennett D, Connor S, Troncoso J, Pletnikova O . Human Herpesvirus 6 Detection in Alzheimer's Disease Cases and Controls across Multiple Cohorts. Neuron. 2020; 105(6):1027-1035.e2. PMC: 7182308. DOI: 10.1016/j.neuron.2019.12.031. View

16.

Cani P, de Vos W . Next-Generation Beneficial Microbes: The Case of . Front Microbiol. 2017; 8:1765. PMC: 5614963. DOI: 10.3389/fmicb.2017.01765. View

17.

Mangani D, Weller M, Roth P . The network of immunosuppressive pathways in glioblastoma. Biochem Pharmacol. 2016; 130:1-9. DOI: 10.1016/j.bcp.2016.12.011. View

18.

Reitman Z, Parsons D, Yan H . IDH1 and IDH2: not your typical oncogenes. Cancer Cell. 2010; 17(3):215-6. PMC: 4467912. DOI: 10.1016/j.ccr.2010.02.024. View

19.

Wang W, Zhang N, Du Y, Gao J, Li M, Lin L . Three-Dimensional Quantitative Imaging of Native Microbiota Distribution in the Gut. Angew Chem Int Ed Engl. 2020; 60(6):3055-3061. DOI: 10.1002/anie.202010921. View

20.

Dawson M, Kouzarides T . Cancer epigenetics: from mechanism to therapy. Cell. 2012; 150(1):12-27. DOI: 10.1016/j.cell.2012.06.013. View